Search results for "ONCOGENI"

showing 10 items of 23 documents

2018

Oncogenic human papillomaviruses (HPV) are small DNA viruses that infect keratinocytes. After HPV binding to cell surface receptors, a cascade of molecular interactions mediates the infectious cellular internalization of virus particles. Aside from the virus itself, important molecular players involved in virus entry include the tetraspanin CD151 and the epidermal growth factor receptor (EGFR). To date, it is unknown how these components are coordinated in space and time. Here, we studied plasma membrane dynamics of CD151 and EGFR and the HPV16 capsid during the early phase of infection. We find that the proteinase ADAM17 activates the extracellular signal-regulated kinases (ERK1/2) pathway…

Keratinocytes0301 basic medicineCarcinogenesisvirusesEndocytic cycle610 MedizinTetraspanin610 Medical sciencesEpidermal growth factor receptorBiology (General)InternalizationPapillomaviridaemedia_commonHuman papillomavirus 16Microbiology and Infectious DiseaseADAM17General NeuroscienceQRoncogenic PapillomavirusGeneral MedicineEndocytosisCell biologyErbB ReceptorsCapsidMedicinemicrodomainsResearch ArticleHumanQH301-705.5MAP Kinase Signaling SystemSciencemedia_common.quotation_subject030106 microbiologyADAM17 ProteinTetraspanin 24BiologyGeneral Biochemistry Genetics and Molecular BiologyVirus03 medical and health sciencesCell surface receptorViral entrygrowth factorsHumansGeneral Immunology and MicrobiologyCell MembranePapillomavirus InfectionsVirionentry receptor complexCell BiologyVirus Internalizationtetraspanin030104 developmental biologybiology.proteinHeLa CellseLife
researchProduct

Demonstration of antibodies to the surface (anti-p41) and core proteins (anti-p24) of the human immunodeficiency virus (HIV) in individuals positive …

1987

Diagnosis of infection with the human immunodeficiency virus (HIV) relies on the demonstration of antibody to this virus. Occasionally, the combined analysis of sera using ELISA and western blot reveals false-positive results. We have compared a newly developed test to detect antibodies to the core (anti-p24) and surface (anti-p41) proteins of HIV with the established tests described above. Anti-p24 and anti-p41 were negative in three individuals positive for anti-HIV by ELISA and immunoblot; they had a low risk to acquire HIV infection and were clinically and immunologically normal and suspected false positive previously. In 62 individuals at risk, anti-p41 was always positive while anti-p…

MaleRiskRetroviridae Proteins OncogenicHuman immunodeficiency virus (HIV)Retroviridae ProteinsEnzyme-Linked Immunosorbent AssayHIV Antibodiesmedicine.disease_causeAntibodies ViralVirusAcquired immunodeficiency syndrome (AIDS)Western blotViral Envelope ProteinsAntibody SpecificityDrug DiscoverymedicineHumansGenetics (clinical)Acquired Immunodeficiency Syndromebiologymedicine.diagnostic_testAnti hivvirus diseasesHIVCore proteinGeneral Medicinemedicine.diseaseVirologyHIV Envelope Protein gp41Immunologybiology.proteinMolecular MedicineFemaleAntibodyKlinische Wochenschrift
researchProduct

Glucocorticoid receptor knockdown decreases the antioxidant protection of B16 melanoma cells: an endocrine system-related mechanism that compromises …

2014

We previously reported an interorgan system in which stress-related hormones (corticosterone and noradrenaline), interleukin-6, and glutathione (GSH) coordinately regulate metastatic growth of highly aggressive B16-F10 melanoma cells. Corticosterone, at levels measured in tumor-bearing mice, also induces apoptotic cell death in metastatic cells with low GSH content. In the present study we explored the potential role of glucocorticoids in the regulation of metastatic cell death/survival during the early stages of organ invasion. Glucocorticoid receptor (GCR) knockdown decreased the expression and activity of γ-glutamylcysteine synthetase (γ-GCS), the rate-limiting step in GSH synthesis, in …

MaleTumor PhysiologyGlutathione reductaseCancer TreatmentMelanoma ExperimentalGene Expressionlcsh:MedicineBiochemistryAntioxidantsMetastasisAnalytical Chemistrychemistry.chemical_compoundOxidative DamageMiceGlucocorticoid receptorSpectrum Analysis TechniquesCell SignalingNeoplasmsMolecular Cell BiologyBasic Cancer ResearchMedicine and Health SciencesNeoplasm Metastasislcsh:Sciencechemistry.chemical_classificationMultidisciplinaryCell DeathGlutathione peroxidaseEndocrine TherapyFlow CytometryGlutathioneChemistrymedicine.anatomical_structureOncologyResearch DesignSpectrophotometryPhysical SciencesCytophotometryGlucocorticoidmedicine.drugResearch ArticleSignal Transductionmedicine.medical_specialtyEndotheliumClinical Research DesignCell SurvivalGlutamate-Cysteine LigaseDown-RegulationEndocrine SystemBiologyResearch and Analysis MethodsCell LineReceptors GlucocorticoidInternal medicineCell Line TumormedicineGeneticsAnimalsHumansAnimal Models of DiseaseOncogenic Signalinglcsh:RBiology and Life SciencesEndothelial CellsGlutathioneCell BiologyMice Inbred C57BLEndocrinologyHEK293 CellschemistryCell cultureCancer cellAnimal Studieslcsh:QEndothelium VascularCytometryPLoS ONE
researchProduct

Non-local multiscale approach for the impact of go or grow hypothesis on tumour-viruses interactions

2021

International audience; We propose and study computationally a novel non-local multiscale moving boundary mathematical model for tumour and oncolytic virus (OV) interactions when we consider the go or grow hypothesis for cancer dynamics. This spatio-temporal model focuses on two cancer cell phenotypes that can be infected with the OV or remain uninfected, and which can either move in response to the extracellular-matrix (ECM) density or proliferate. The interactions between cancer cells, those among cancer cells and ECM, and those among cells and OV occur at the macroscale. At the micro-scale, we focus on the interactions between cells and matrix degrading enzymes (MDEs) that impact the mov…

Non-local cell adhesion[SDV]Life Sciences [q-bio]Multiscale cancer modellingBiologyMatrix (biology)Models BiologicalVirusMigration-proliferation dichotomyExtracellular matrix03 medical and health sciences0302 clinical medicineNeoplasmsmedicineQA1-939HumansNeoplasm Invasiveness[NLIN]Nonlinear Sciences [physics][MATH]Mathematics [math]030304 developmental biology0303 health sciencesApplied MathematicsCancerGo or grow hypothesisGeneral Medicinemedicine.diseasePhenotypeExtracellular MatrixCell biologyOncolytic virusOncolytic VirusesComputational MathematicsViral replication030220 oncology & carcinogenesisModeling and SimulationTumour-oncolytic viruses interactionsCancer cellOncogenic VirusesGeneral Agricultural and Biological SciencesTP248.13-248.65MathematicsBiotechnology
researchProduct

Oncogene Addiction in Solid Tumors

2015

The term “oncogenic addiction” refers to the phenomenon by which tumor cells become completely dependent on a single pathway, derived from the activation of a specific oncogene, for their survival and proliferation. The clinical relevance of oncogene addiction paradigm is highlighted by a growing number of examples that demonstrate the efficacy of several therapeutic agents that target specific oncogenes in various cancer types. This chapter aims to summarize the recent evidences concerning the concept of oncogene addiction and describes molecular mechanisms that could explain this phenomenon.

OncogeneCombination therapybusiness.industrymedicine.medical_treatmentCancerOncogenic Addictionmedicine.disease_causeOncogene Addictionmedicine.diseaseTargeted therapyCancer cellCancer researchmedicinebusinessCarcinogenesis
researchProduct

Intraoperative Adjuvant Hyperthermic Intraperitoneal Chemotherapy in Patients with Locally Advanced Colon Cancer: A Prospective Parallel Phase II Stu…

2020

.Background: Prophylactic hyperthermic intraperitoneal chemotherapy (HIPEC) showed promising results in patients with colorectal carcinoma at high risk of recurrence but still without clinically and radiologically evident signs of peritoneal spread. This study aims to analyze the feasibility of this proactive, early phase, multimodality approach. Methods: A mono-institutional, prospective, parallel, two-stage phase II trial enrolled 49 patients to standard surgery or surgery plus intraoperative HIPEC. Before the procedure and during surgery, patients received intravenous fluorouracil (and leucovorin to potentiate oxaliplatin activity. Data analysis included length of hospital stay, surgery …

OncologyPeritoneal metastasismedicine.medical_specialtybusiness.industryColorectal cancermedicine.medical_treatmentLocally advancedPhases of clinical researchmedicine.diseaseText miningInternal medicinemedicineIn patientHyperthermic intraperitoneal chemotherapybusinessAdjuvantoncology_oncogenics
researchProduct

Gold Nanoparticle-Assisted Virus Formation by Means of the Delivery of an Oncolytic Adenovirus Genome

2020

[EN] Oncolytic adenoviruses are a therapeutic alternative to treat cancer based on their ability to replicate selectively in tumor cells. However, their use is limited mainly by the neutralizing antibody (Nab) immune response that prevents repeated dosing. An alternative to facilitate the DNA access to the tumor even in the presence of anti-viral Nabs could be gold nanoparticles able to transfer DNA molecules. However, the ability of these nanoparticles to carry large DNA molecules, such as an oncolytic adenovirus genome, has not been studied. In this work, gold nanoparticles were functionalized with different amounts of polyethylenimine to transfer in a safe and efficient manner a large on…

Oncolytic adenovirusVirus oncogènicsOncolytic virusvirusesGeneral Chemical EngineeringGenetic enhancement02 engineering and technologyArticleViruslcsh:ChemistryNanofluids03 medical and health scienceschemistry.chemical_compoundGene therapyPlasmidCIENCIA DE LOS MATERIALES E INGENIERIA METALURGICAnon-viral vectorsGold nanoparticlescancerGeneral Materials ScienceVirotherapyCàncerCancer030304 developmental biologyoncolytic virus0303 health sciencesOncogenic virusesVirotherapyQUIMICA INORGANICATransfection021001 nanoscience & nanotechnologyVirologygene therapyOncolytic viruslcsh:QD1-999chemistrygold nanoparticlesNon-viral vectorsdeliveryvirotherapy0210 nano-technologyDeliveryDNANanomaterials
researchProduct

Quercetin and MicroRNA Interplay in Apoptosis Regulation in Ovarian Cancer

2020

The multifaceted nature of ovarian cancer has severely hampered the development of effective therapeutics over the years. The complicate nature of ovarian cancer makes it therapeutically challenging, therefore, there has been a renewed interest in phytochemistry. Phytochemicals have emerged as a potential therapeutic option due to less side effects. Moreover, the signaling inhibition properties have also been studied extensively in recent times. A growing number of data obtained via high-throughput technologies has started to delineate the complex oncogenic signaling networks, thus broadening the therapeutic opportunities. Within the network, microRNAs (miRNAs) have been shown to play a ve…

PhytochemicalsApoptosisCarcinoma Ovarian EpithelialBiologyTherapeutic approachchemistry.chemical_compoundOvarian cancerDrug DiscoveryOncogenic signalingmicroRNAmedicineHumansSettore BIO/06 - Anatomia Comparata E CitologiaCytotoxicityOvarian NeoplasmsPharmacologyChemo-preventive agentCancermedicine.diseaseMicroRNAschemistryApoptosismiRNAsCancer researchFemaleQuercetinOvarian cancerQuercetin
researchProduct

Molecular Characterization of a Long Term Survivor Double Metastatic Non Small Sell Lung Cancer and Pancreatic Ductal Adenocarcinoma Treated with Gef…

2019

Management of multiple primary cancers, a not so infrequent event in oncology practice, is a critical issue due to the lack of literature . In this study, we reported the case of a patient with metachronous double metastatic non small cell lung cancer (NSCLC) and pancreatic ductal adenocarcinoma (PDAC) who received gefitinib in combination with gemcitabine plus nab-paclitaxel and with mFOLFOX6 in first and second line, respectively. She achieved a progression free survival and an overall survival (OS) of 28 months for NSCLC and PFS-1 and OS of 20 and 13 months, respectively for PDAC. Moreover, the combination of gefitinib and chemotherapies treatments displayed a good safety profile. Given …

Second-line therapyChemotherapyPancreatic ductal adenocarcinomabusiness.industrymedicine.medical_treatmentLong Term Survivormedicine.diseaseGemcitabineGefitinibCancer researchmedicineLung cancerbusinessoncology_oncogenicsmedicine.drugNab-paclitaxel
researchProduct

The effects of HPV infection on semen: first results from a new approach.

2017

Study question: The effect of HPV infection on semen characteristics was investigated using a new method that allow to evaluate virus localization in the different semen components. Summary answer: Our data indicate a correlation between HPV infection of exfoliated epithelial cells (from spermatic ducts and accessory glands) and reduction of sperm cell motility. What is known already: HPVs are agents of the most common sexually transmitted diseases. Both in men and in women, HPVs cause a variety of clinical symptoms ranging from warts to cancer. It has been shown (IARC, 2009) that infection with 12 oncogenic HPVs is the major cause of development of cervical cancer in women and it is also r…

Settore MED/07 - Microbiologia E Microbiologia ClinicaSexually transmitted diseases oncogenic viruses HPV infection semen parameters male infertilitySettore BIO/11 - Biologia MolecolareSettore BIO/06 - Anatomia Comparata E Citologia
researchProduct